«Currently, there are three phase - three clinical trials for a dengue vaccine and UNC is collaborating
with vaccine developers to understand data from these trials.»
Currently, there are three phase - three clinical trials for a dengue vaccine and UNC is collaborating
with vaccine developers to understand data from these trials, de Silva said.
Not exact matches
The so - called «human challenge model» has a long and checkered past that began
with 18th century experiments by smallpox
vaccine developer Edward Jenner and later fell under intense scrutiny when they were conducted by Nazi doctors, military researchers, and academic scientists working
with prisoners.
Vaccine developers are trying to improve vaccines for transplant recipients and other people with a weak immune system, and the samples used in this study came from a clinical trial of different versions of a flu vaccine in patients on immune - suppressive
Vaccine developers are trying to improve
vaccines for transplant recipients and other people
with a weak immune system, and the samples used in this study came from a clinical trial of different versions of a flu
vaccine in patients on immune - suppressive
vaccine in patients on immune - suppressive drugs.
Through development of recombinant viral
vaccines,
developers can reduce risks associated
with the presence of live and inactivated viruses.
Ownership of
vaccine candidates and biomarkers and any intellectual property rights remain
with researchers and
vaccine developers.